FTC, Amgen reach deal to allow $28 billion pharmaceutical merger
Washington Post
The Federal Trade Commission dropped its lawsuit to block Amgen’s merger with Horizon Therapeutics, reaching a deal it said would prevent anticompetitive behavior.
https://www.washingtonpost.com/business/2023/09/01/amgen-horizon-ftc-lawsuit/